Total Versus Subtotal Abdominal Hysterectomy at Time of Abdominal Sacrocolpopexy
NCT ID: NCT04178473
Last Updated: 2021-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2019-01-01
2021-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study the investigator will compare the result of total versus subtotal hysterectomy at the time of sacrocolpopexy.
Study design: Randomized controlled trial
Intervention:
Group A will have total abdominal hysterectomy Group B will have subtotal abdominal hysterectomy
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal Hysterectomy vs Supracervical Hysterectomy at the Time of Sacrocolpopexy
NCT04797585
Abdominal Sacral Hysteropexy Versus Vaginal Sacrospinous Hysteropexy
NCT04850365
Abdominal Pectopexy Versus Abdominal Sacral Hysteropexy.
NCT04856709
Abdominal Versus Vaginal Hysteropexy
NCT03494582
Total Laparoscopic Hysterectomy With Sacrocolpopexy Versus Total Laparoscopic Hysterectomy With Lateral Suspension in Patients With Pelvic Organ Prolapse
NCT03722563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study the investigator will compare the result of total versus subtotal hysterectomy at the time of sacrocolpopexy.
Patients and methods
Study design:
Randomized controlled trial
Patients:
Data will be collected from the patients admitted to the obstetrics and gynecology department, Qen faculty of medicine, South Valley University, Egypt from the 1st of January 2019 until 30th of December 2019. Follow up data will be collected until 30th of December 2020. Written consent will be obtained at time of recruitment. The Inclusion criteria are nonhystrectomized patients who will undergo sacrocolpopexy. Exclusion criteria were (1) women age less than 40; (2) desire to retain the uterus; (3) women who are unfit for lengthy surgery. Randomization will be through closed envelop method.
Intervention Group A will have total abdominal hysterectomy Group B will have subtotal abdominal hysterectomy Sacrocolpopexy will be done using Polypropylene mesh. Both groups will be done by the same surgeon using the following technique: dissection of the vesicovaginal and the rectovaginal spaces to prepare for the site of mesh placement. Dissection will be continued in the rectovaginal septum using sharp and blunt dissection until reaching the level of the levator ani (the length of the posterior vaginal mesh arm is nearly equal to the total vaginal length). The limit of the dissection in the vesicovaginal plane is down to the bladder neck (known by palpation of the Foley's catheter balloon) after lateralization of the ureters. The mesh is sutured to the anterior and the posterior vaginal wall the mesh using non-absorbable sutures. In women with subtotal hysterectomy, the mesh will be also sutured to the cervix. The mesh is then sutured to the anterior longitudinal ligament on the anterior surface of the fifth lumbar vertebra and the sacral promontory using non-absorbable sutures. Suturing of the peritoneum over the mesh will be done.
Outcomes:
The primary outcome will be mesh erosion. Secondary outcomes will be complications including recurrence
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
total abdominal hysterectomy
Total abdominal hysterectomy at the time of sacrocolpopexy operation for uterovaginal prolapse
total abdominal hysterectomy
total abdominal hysterectomy at time of sacrocolpopexy
subtotal abdominal hysterectomy
subtotal abdominal hysterectomy at the time of sacrocolpopexy operation for uterovaginal prolapse
Subtotal abdominal hysterectomy
Subtotal abdominal hysterectomy at time of sacrocolpopexy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
total abdominal hysterectomy
total abdominal hysterectomy at time of sacrocolpopexy
Subtotal abdominal hysterectomy
Subtotal abdominal hysterectomy at time of sacrocolpopexy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* desire to retain the uterus
* women who are unfit for lengthy surgery
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South Valley University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammad Abdel-Rahman Mohammad Ahmed
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammad AM Ahmed, MD
Role: PRINCIPAL_INVESTIGATOR
South Valley University, Qena Faculty of Medicine, Obstetrics and Gynecology Department, Qena, Qena, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
South Valley University, Qena Faculty of Medicine, Obstetrics and Gynecology Department
Qina, Qena Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barrington JW, Edwards G. Posthysterectomy vault prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(4):241-5. doi: 10.1007/s001920070033.
Cayrac M, Warembourg S, Le Normand L, Fatton B. [Does hysterectomy modifies the anatomical and functional outcomes of prolapse surgery?: Clinical Practice Guidelines]. Prog Urol. 2016 Jul;26 Suppl 1:S73-88. doi: 10.1016/S1166-7087(16)30430-4. French.
Coolen AWM, Bui BN, Dietz V, Wang R, van Montfoort APA, Mol BWJ, Roovers JWR, Bongers MY. The treatment of post-hysterectomy vaginal vault prolapse: a systematic review and meta-analysis. Int Urogynecol J. 2017 Dec;28(12):1767-1783. doi: 10.1007/s00192-017-3493-2. Epub 2017 Oct 16.
Cundiff GW, Varner E, Visco AG, Zyczynski HM, Nager CW, Norton PA, Schaffer J, Brown MB, Brubaker L; Pelvic Floor Disorders Network. Risk factors for mesh/suture erosion following sacral colpopexy. Am J Obstet Gynecol. 2008 Dec;199(6):688.e1-5. doi: 10.1016/j.ajog.2008.07.029. Epub 2008 Oct 31.
Ismail S, Duckett J, Rizk D, Sorinola O, Kammerer-Doak D, Contreras-Ortiz O, Al-Mandeel H, Svabik K, Parekh M, Phillips C. Recurrent pelvic organ prolapse: International Urogynecological Association Research and Development Committee opinion. Int Urogynecol J. 2016 Nov;27(11):1619-1632. doi: 10.1007/s00192-016-3076-7. Epub 2016 Jul 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OBGYN 0101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.